IDPH--Positive preliminary results for pivotal trial of ID Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : IDPH--Positive preliminary results for pivotal trial of ID

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Roudy who wrote (233)	12/15/1996 2:57:00 PM
From: Don Cheng	of 1762

Hi Don, I was just reading the news from Barrons Dossier. Here is the news. WASHINGTON (Dow Jones)-- A group including SmithKline Beecham PLC (SBH) cut its stake in IDEC Pharmaceuticals Corp. (IDPH) to 11.3%. In a filing with the Securities and Exchange Commission, the group said it sold 400,000 common shares between Dec. 2 and Dec. 4 at prices ranging from $24.19 to $25.44 a share, and now holds about 2 million shares of the San Diego firm. The group said it exercised warrants to purchase the 400,000 shares on Oct. 30. I don't know where you got yours. Please confirm your resource. Don

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next